osteoarthritis, osteonecrosis of femoral head
Conditions
Interventions
experimental group:The patient was subcutaneously injected with erythropoietin after THA
control group:Nil
Sponsors
Affiliated Hospital of Xuzhou Medical University
Eligibility
Sex/Gender
All
Age
18 Years to 90 Years
Inclusion criteria
Inclusion criteria: Patients who were 18 years or older and diagnosed as osteoarthritis or osteonecrosis of femoral head were recruited in this study.
Exclusion criteria
Exclusion criteria: 1) were contraindicated to rHu-EPO; 2) had lower extremity deep venous thrombosis (DVT), pulmonary embolism or myocardial infarction and receive anticoagulant therapy or antiplatelet treatment recently; 3) had severe liver diseases, uncontrolled hypertension, clinically significant impairment of renal function or any other organ insufficiencies; 4) preoperative Hb < 90g/l; 5) had a history of hip fracture or required additional osteotomy during THA.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| weight; | — |
Secondary
| Measure | Time frame |
|---|---|
| age;height; | — |
Countries
China
Contacts
Public ContactKaijin Guo
Affiliated Hospital of Xuzhou Medical University
Outcome results
None listed